35
Views
2
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

IFN-λs and BDCA3+/CD8α+ dendritic cells: towards the design of novel vaccine adjuvants?

&
Pages 159-161 | Published online: 09 Jan 2014

References

  • Li M, Liu X, Zhou Y, Su SB. Interferon-λs: the modulators of antivirus, antitumor, and immune responses. J. Leukoc. Biol.86(1), 23–32 (2009).
  • Ank N, Iversen MB, Bartholdy C et al. An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J. Immunol.180(4), 2474–2485 (2008).
  • Steinman RM. Dendritic cells: understanding immunogenicity. Eur. J. Immunol.37(Suppl. 1), S53–S60 (2007).
  • Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol.164(6), 2978–2986 (2000).
  • Bachem A, Güttler S, Hartung E et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med.207(6), 1273–1281 (2010).
  • Crozat K, Guiton R, Contreras V et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells. J. Exp. Med.207(6), 1283–1292 (2010).
  • Jongbloed SL, Kassianos AJ, McDonald KJ et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med.207(6), 1247–1260 (2010).
  • Poulin LF, Salio M, Griessinger E et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells. J. Exp. Med.207(6), 1261–1271 (2010).
  • Contreras V, Urien C, Guiton R et al. Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J. Immunol.185(6), 3313–3325 (2010).
  • Barchet W, Wimmenauer V, Schlee M, Hartmann G. Accessing the therapeutic potential of immunostimulatory nucleic acids. Curr. Opin. Immunol.20(4), 389–395 (2008).
  • Trumpfheller C, Caskey M, Nchinda G et al. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl Acad. Sci. USA105(7), 2574–2579 (2008).
  • Stahl-Hennig C, Eisenblätter M, Jasny E et al. Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. PLoS Pathog.5(4), e1000373 (2009).
  • Longhi MP, Trumpfheller C, Idoyaga J et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med.206(7), 1589–1602 (2009).
  • Lauterbach H, Bathke B, Gilles S et al. Mouse CD8α+ DCs and human BDCA3+ DCs are major producers of IFN-λ in response to poly IC. J. Exp. Med.207(12), 2703–2717 (2010).
  • Morrow MP, Yan J, Pankhong P et al. IL-28B/IFN-λ 3 drives granzyme B loading and significantly increases CTL killing activity in macaques. Mol. Ther.18(9), 1714–1723 (2010).
  • Morrow MP, Yan J, Pankhong P et al. Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques. Clin. Vaccine Immunol.17(10), 1493–1499 (2010).
  • Ichinohe T, Ainai A, Tashiro M, Sata T, Hasegawa H. PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants. Vaccine27(45), 6276–6279 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.